Geode Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-212,835
Closed -$4.62M – 4109
2017
Q2
$4.62M Buy
212,835
+8,354
+4% +$152K ﹤0.01% 2197
2017
Q1
$2.87M Buy
204,481
+6,853
+3% +$112K ﹤0.01% 2450
2016
Q4
$3.71M Buy
197,628
+6,542
+3% +$111K ﹤0.01% 2256
2016
Q3
$3.15M Buy
191,086
+2,622
+1% +$38.8K ﹤0.01% 2265
2016
Q2
$2.53M Buy
188,464
+2,726
+1% +$39.8K ﹤0.01% 2337
2016
Q1
$2.84M Buy
185,738
+21,565
+13% +$338K ﹤0.01% 2219
2015
Q4
$3.26M Buy
164,173
+1,381
+0.8% +$26.2K ﹤0.01% 2164
2015
Q3
$2.84M Buy
162,792
+11,546
+8% +$235K ﹤0.01% 2208
2015
Q2
$3.06M Buy
151,246
+15,220
+11% +$294K ﹤0.01% 2237
2015
Q1
$2.39M Buy
136,026
+3,546
+3% +$60.4K ﹤0.01% 2331
2014
Q4
$2.16M Buy
132,480
+16,758
+14% +$308K ﹤0.01% 2379
2014
Q3
$2.55M Sell
115,722
-22,220
-16% -$455K ﹤0.01% 2207
2014
Q2
$2.78M Sell
137,942
-8,668
-6% -$147K ﹤0.01% 2177
2014
Q1
$2.72M Sell
146,610
-175,902
-55% -$2.42M ﹤0.01% 2159
2013
Q4
$3.25M Buy
322,512
+164,086
+104% +$1.98M ﹤0.01% 2000
2013
Q3
$2.04M Buy
158,426
+54,116
+52% +$666K ﹤0.01% 2157
2013
Q2
$1.24M Buy
+104,310
New +$1.13M ﹤0.01% 2345

Other funds holding AMRI

Geode Capital Management's AMRI Position: Q3 2017 in Review

Geode Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 212,835 shares — an estimated $4.62M sold.

Geode Capital Management first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $4.62M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Geode Capital Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Geode Capital Management sold 212,835 Albany Molecular Research Inc shares in Q3 2017, an estimated $4.62M.
  • Geode Capital Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
  • Geode Capital Management's Albany Molecular Research Inc position peaked at $4.62M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Geode Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.